Stock CD0 STEEP HILL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Steep Hill Inc. Stock Deutsche Boerse AG

Equities

CD0

CA85832P2089

Pharmaceuticals

Market Closed - Deutsche Boerse AG
Other stock markets
 02:01:53 2024-05-17 EDT 		5-day change 1st Jan Change
0.0105 EUR 0.00% Intraday chart for Steep Hill Inc. -19.23% -38.24%
04-16 Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Steep Hill Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 3.07 2.83 4.18 Sales 2023 - Capitalization 567K 521K 771K
Net income 2022 -7M -6.44M -9.53M Net income 2023 - 0 0 EV / Sales 2022 -199,457 x
Net cash position 2022 1.83M 1.69M 2.49M Net cash position 2023 2.59M 2.39M 3.53M EV / Sales 2023 -
P/E ratio 2022
-0.17 x
P/E ratio 2023
0.71 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 97.89%
More Fundamentals * Assessed data

Chart Steep Hill Inc.

Dynamic Chart

Latest news about Steep Hill Inc.

Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Steep Hill Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Steep Hill Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Steep Hill Inc. Announces Demise of Director, David Walters CI
Steep Hill Inc. Announces Chief Financial Officer Change CI
Steep Hill Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Steep Hill Inc. Auditor Raises 'Going Concern' Doubt CI
Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Steep Hill Inc. Enters into a Settlement and Release Agreement CI
Steep Hill Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Steep Hill Inc. to Close Canadian Lab and Focus on US Operations CI
Steep Hill Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Steep Hill Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Steep Hill Michigan Achieves ISO 17025:2017 Accreditation CI
Steep Hill Inc. Enters into A Licensing Agreement with SH Lab Holdings LLC, Expanding Its Network of Licensees to the State of Vermont CI
More news

Press releases Steep Hill Inc.

Steep Hill Announces Consolidation NE
Steep Hill Settles Indemnification Lawsuit NE
Steep Hill Mourns the Passing of Board Member, David Walters NE
Steep Hill Announces CFO Change NE
CSE Bulletin: Name and Symbol Change - Canbud Distribution Corporation (CBDX) NE
More press releases

Quotes and Performance

1 week-19.23%
Current month+5.00%
1 month+5.00%
3 months-38.24%
6 months+40.00%
Current year-38.24%
More quotes

Highs and lows

1 week
0.01
Extreme 0.0105
0.01
1 month
0.01
Extreme 0.0075
0.02
Current year
0.00
Extreme 0.003
0.02
1 year
0.00
Extreme 0.003
0.09
3 years
0.00
Extreme 0.003
0.35
5 years
0.00
Extreme 0.003
0.35
10 years
0.00
Extreme 0.003
0.35
More quotes

Managers and Directors - Steep Hill Inc.

Managers TitleAgeSince
Sameet Kanade CEO
 Chief Executive Officer - 22-01-31
Zavosh Zaboliyan IRC
 Investor Relations Contact - -
Adrian Burke SAM
 Sales & Marketing - 21-01-06
Members of the board TitleAgeSince
Jane Wright-Mitchell BRD
 Director/Board Member 55 21-10-07
David Walters BRD
 Director/Board Member 63 20-05-28
Sameet Kanade CEO
 Chief Executive Officer - 22-01-31
More insiders

Quotes

Date Price Change
24-05-17 0.0105 0.00%
24-05-16 0.0105 -19.23%
24-05-15 0.013 0.00%
24-05-14 0.013 0.00%
24-05-13 0.013 0.00%

Delayed Quote Deutsche Boerse AG, May 17, 2024 at 02:01 am

More quotes

Company Profile

Steep Hill Inc. is a Canada-based company. The Company is engaged in the process of restructuring its business and is exploring strategic alternatives.
Sector
Pharmaceuticals
Calendar
2024-05-27 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

1st Jan change Capi.
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+42.38% 6.26B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.86% 4.49B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+6.36% 3.29B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-11.28% 3.12B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-3.23% 2.5B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+45.24% 1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.89% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-0.98% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-11.32% 1.56B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. STPH Stock
  4. CD0 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW